Modern approaches to the management of insomnia in general therapeutic practice
https://doi.org/10.21518/2079-701X-2019-6-20-26
Abstract
The article is devoted to the extremely common problem of modern medicine - sleep disorders. Insomnia in a variety of manifestations faced by doctors of different specialties. This review introduces practitioners to the modern classification and approaches to the diagnosis of insomnia. Both pharmacological and non-pharmacological methods of treatment and criteria for their effectiveness are discussed. Advantages of Donormil in insomnia treatment was demonstrated.
About the Authors
O. V. KurushinaRussian Federation
Kurushina Olga Viktorovna – Dr. of Sci. (Med.), Head of Chair for Neurology, Neurosurgery, Medical Genetics with Course of Neurology, Manual Therapy, Reflexotherapy, Department of Continuing Medical Education
400131, Volgograd, pl. Pavshikh Bortsov, 1
A. E. Barulin
Russian Federation
Barulin Alexander Evgenyevich – Dr. of Sci. (Med.), Head of Course of Neurology, Manual Therapy, Reflexotherapy, Department of Continuing Medical Education
400131, Volgograd, pl. Pavshikh Bortsov, 1
D. Ya. Bagirova
Russian Federation
Bagirova Dilara Yasharovna – Assistant Professor of Chair for Neurology, Neurosurgery, Medical Genetics with Course of Neurology, Manual Therapy, Reflexotherapy, Department of Continuing Medical Education
400131, Volgograd, pl. Pavshikh Bortsov, 1
References
1. Lichstein KL, Taylor DJ, McCrae CS, Petrov ME. Insomnia: epidemiology and risk factors. Principles and Practice of Sleep Medicine. 6th ed. Philadelphia: Elsevier, 2016:761-768.
2. Wayne A.M. Sleep disorders. The main pathogenetic mechanisms. Correction methods. St. Petersburg: MIA, 1995:6-12. (In Russ).
3. American Academy of Sleep Medicine. International classification of sleep disorders 3 ed.: Diagnostic and coding manual. Westchester, Ill.: American Academy of Sleep Medicine, 2014.
4. Golenkov A.V., Poluektov M.G. Prevalence of sleep disorders in Chuvashia residents (data from the blanket questionnaire survey) Zhurn. Nevrozov i Psikhiat. (In Russ).
5. Levin Ya.I., Kovrov G.V. Cradlesong on prescription. Sleep disturbances and their correction. RMJ. 2003;3(3). (In Russ).
6. Levin Ya.I., Kovrov G.V., Poluektov M.G., Korabelnikova E.A., Strygin K.N., Tarasov B.A., Posokhov S.I. Insomnia, modern diagnostic and therapeutic approaches. M.: Medpraktika-M, 2005. (In Russ).
7. Kurushina O.V., Barulin A.E., Babushkin Y.K., Kurakova E.A. Sleep disturbance in somatic practice. Vestnik Volgogradskogo Gosudarstvennogo Meditsinskogo Universiteta. 2013;4(48):3-7. (In Russ).
8. Kurushina OV, Bagirova D.Ya., Yakovlev S.S. The effect of insufficient sleep duration on cognitive function. Actual problems of experimental and clinical medicine. Materials of the 75th Open Scientifically-Practical Conference of young scientists and students of Volgograd State Medical University with international participation. 2017. p. 99. (In Russ).
9. Okovity S.V., Titovich I.A. Pharmacological principles of insomnia therapy. Meditsinsky Sovet. 2018;6:26- 30. (In Russ).
10. Strygin K.N., Poluektov M.G. Insomnia. Meditsinsky Sovet. 2017;0:52-57. (In Russ).
11. American Academy of Sleep Medicine. International classification of sleep disorders, 2nd ed.: Diagnostic and coding manual. Westchester, Ill.: American Academy of Sleep Medicine, 2005.
12. Bassetti C. Sleep and stroke. In: Principles and practice of sleep medicine [edited by]. M.H. Kryger, T. Roth, W.C. Dement. 5th ed. St. Louis, Missouri: Elsevier Saunders 2011:993-1015.
13. Buysse D.J., Hall M.L., Strollo P.J., Kamarck T.W., Owens J., Lee L., Reis S.E., Matthews K.A. Relationships between the Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale (ESS), and clinical/polysomnographic measures in a community sample. J Clin Sleep Med. 2008;4(6):563-571.
14. Cardinali D.P., Srinivasan V., Brzezinski A., Brown G.M. Melatonin and its analogs in insomnia and depression. J Pineal Res. 2012;52(4):365- 375.
15. Schadeck S.B., Chelly M., Amsellem D. et al. Comparative efficacy of doxylamine (15 mg) and zolpidem (10 mg) for the treatment of common insomnia – a placebo-controlled study. Sep Hop Pari. 1996;72(13-14):428-439.
16. Kovalzon V.M., Strygin K.N. Neurochemical mechanisms of sleep-wake regulation: the role of histamine receptors blockers in the treatment of insomnia. Effective Pharmacotherapy. 2013;12:8-14. (In Russ.)
17. Babak S.L., Golubev L.A., Gorbunova M.V. Chronic insomnia in the clinical practice of the therapist. RMJ. 2008;16(5):259-266. (In Russ.)
18. Adamenko R.Ya. Treat ment of insomnia in patients with chronic cerebrovascular insufficiency. Zhurnal Prakticheskogo Vracha. 2001;5:45-51. (In Russ.)
19. Levin Ya.I. Sleep, insomnia, doxylamine (Donormil). RMJ. 2007;15(10):850-855. (In Russ.)
20. Patient Information Leaflet for Ivadal® P No 14944/01 https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=2afc1131-55b7-459e-8de3- c55e659fec46&t= (In Russ).
21. Patient Information Leaflet for Imovan® P No. 015904/01 https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=9fe8ba0f-abb5-4280-a637-925b0b67fa51&t=. (In Russ).
22. Patient Information Leaflet for Melaxen at RosMinZdrav website https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=906d1aaf-373c-4f0b-8589-15ceadab9935&t=. (In Russ).
Review
For citations:
Kurushina OV, Barulin AE, Bagirova DY. Modern approaches to the management of insomnia in general therapeutic practice. Meditsinskiy sovet = Medical Council. 2019;(6):20-26. (In Russ.) https://doi.org/10.21518/2079-701X-2019-6-20-26